These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acellular pertussis vaccines and the role of pertactin and fimbriae. Poolman JT; Hallander HO Expert Rev Vaccines; 2007 Feb; 6(1):47-56. PubMed ID: 17280478 [TBL] [Abstract][Full Text] [Related]
25. Evolutionary genomics of recent clinical Bordetella pertussis isolates from Iran: wide circulation of multiple ptxP3 lineages and report of the first ptxP3 filamentous hemagglutinin-negative B. pertussis. Safarchi A; Saedi S; Octavia S; Sedaghatpour M; Bolourchi N; Tay CY; Lamichhane B; Shahcheraghi F; Lan R Infect Genet Evol; 2021 Sep; 93():104970. PubMed ID: 34171476 [TBL] [Abstract][Full Text] [Related]
26. Genotypes of Zhang J; Lin C; Chang L; Wang X; Wei X; Li H Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 51(1):47-52. PubMed ID: 35462464 [TBL] [Abstract][Full Text] [Related]
27. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange. Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455 [TBL] [Abstract][Full Text] [Related]
28. Role of Evolutionary Selection Acting on Vaccine Antigens in the Re-Emergence of Etskovitz H; Anastasio N; Green E; May M Diseases; 2019 Apr; 7(2):. PubMed ID: 30995764 [TBL] [Abstract][Full Text] [Related]
29. Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. de Gouw D; Hermans PW; Bootsma HJ; Zomer A; Heuvelman K; Diavatopoulos DA; Mooi FR PLoS One; 2014; 9(1):e84523. PubMed ID: 24416242 [TBL] [Abstract][Full Text] [Related]
30. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007 [TBL] [Abstract][Full Text] [Related]
31. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209 [TBL] [Abstract][Full Text] [Related]
32. Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site. Zeddeman A; van Schuppen E; Kok KE; van Gent M; Heuvelman KJ; Bart MJ; van der Heide HGJ; Gillard J; Simonetti E; Eleveld MJ; van Opzeeland FJH; van Selm S; de Groot R; de Jonge MI; Mooi FR; Diavatopoulos DA PLoS One; 2020; 15(8):e0237394. PubMed ID: 32822419 [TBL] [Abstract][Full Text] [Related]
33. The importance of Bordetella pertussis strains which do not produce virulence factors in the epidemiology of pertussis. Polak M; Lutyńska A Postepy Hig Med Dosw (Online); 2017 May; 71(0):367-379. PubMed ID: 28513461 [TBL] [Abstract][Full Text] [Related]
34. A Bordetella pertussis acellular vaccine candidate: antigenic characterization and antibody induction. Dias WO; Horton DS; Takahashi CM; Raw I Braz J Med Biol Res; 1994 Nov; 27(11):2607-11. PubMed ID: 7549983 [TBL] [Abstract][Full Text] [Related]
35. Comparative genomics of whole-cell pertussis vaccine strains from India. Alai S; Ghattargi VC; Gautam M; Patel K; Pawar SP; Dhotre DP; Shaligram U; Gairola S BMC Genomics; 2020 May; 21(1):345. PubMed ID: 32381023 [TBL] [Abstract][Full Text] [Related]
36. Effect of vaccination on Bordetella pertussis strains, China. Zhang L; Xu Y; Zhao J; Kallonen T; Cui S; Xu Y; Hou Q; Li F; Wang J; He Q; Zhang S Emerg Infect Dis; 2010 Nov; 16(11):1695-701. PubMed ID: 21029526 [TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan. Miyaji Y; Otsuka N; Toyoizumi-Ajisaka H; Shibayama K; Kamachi K PLoS One; 2013; 8(10):e77165. PubMed ID: 24124606 [TBL] [Abstract][Full Text] [Related]
38. Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB/c Mice. Bakhshaei P; Kazemi MH; Golara M; Abdolmaleki S; Khosravi-Eghbal R; Khoshnoodi J; Judaki MA; Salimi V; Douraghi M; Jeddi-Tehrani M; Shokri F J Interferon Cytokine Res; 2018 Apr; 38(4):161-170. PubMed ID: 29638208 [TBL] [Abstract][Full Text] [Related]
39. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004. Advani A; Donnelly D; Gustafsson L; Hallander HO APMIS; 2007 Apr; 115(4):299-310. PubMed ID: 17504296 [TBL] [Abstract][Full Text] [Related]
40. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012. Bailon H; León-Janampa N; Padilla C; Hozbor D BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]